PPARG and cancer: The involvement of PPARγ in the upregulation of ABCA1 by FaDOH and the formation of LDs cannot be excluded based on our results and therefore further investigations in cells of normal and cancer origin are needed, which may include treatment with PPARγ antagonists to explore the potential anticancer and antidiabetic properties of FaDOH.